OncoNano Medicine, Inc., closed a $11.7 million Series A financing transaction arranged by Salem Partners, who also participated as a principal investor. The Series A funding supplements a $6 million grant previously received from the Cancer Prevention and Research Institute of Texas . OncoNano uses